Condensed Consolidated Statements Of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (4,121,167)	$ (333,113)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Depreciation expense	20,815	12,124
Amortization of patents	51,994	58,778
Common stock and options for compensation, consulting and vendor services	499,049	324,279
Changes in operating assets and liabilities:
Increase in accounts receivable	(807,869)	(91,489)
Increase in related party	(85,959)
Increase in inventories	(307,807)	(919,814)
(Increase) decrease to advances on contracts	(490,729)	996,949
(Increase) decrease to prepaid expenses and other current assets	25,996	(114,807)
Increase in other assets	(2,670)
Decrease in accounts payable	(672,974)	(629,479)
Increase in customer advances		49,441
Increase in accrued expenses and other payables	369,685	95,194
Net cash used in operating activities	(3,762,370)	(3,360)
Cash flows from investing activities:
Notes receivable to Milestone Medical Inc	(2,000,000)
Advances to related parties	(677,991)	(398,810)
Addition to intangible assets	(1,986)
Purchases of property and equipment	(47,613)	(66,130)
Net cash used in investing activities	(2,727,590)	(464,940)
Cash flows from financing activities:
Proceeds from exercise of stock options	12,750	202,781
Repayment of related party loan		(50,000)
Capital contribution from noncontrolling interest	500,000
Net cash provided by financing activities	512,750	9,602,464
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(5,977,210)	9,134,164
Cash and cash equivalents at beginning of period	10,367,993	1,147,198
Cash and cash equivalents at end of period	4,390,783	10,281,362
Supplemental disclosure of cash flow information:
Shares issued to directors for the exercise of stock options		41,250
Shares issued to directors for compensation		55,200
Shares to be issued to employees for bonuses	100,000
Shares issued to employees for exercise of stock options		104,615
Shares issued to employees in lieu of cash compensations	42,500	35,624
Shares issued to consultants for exercise of stock options	60,000	199,500
Net proceeds on Private Placement Offering		56,916
May 2014 [Member]
Cash flows from financing activities:
Net proceeds on Private Placement Offering		9,449,683
Milestone Medical Inc. [Member]
Adjustments to reconcile net loss to net cash (used in) operating activities:
Equity (earnings) loss on joint venture	1,566,711	567,550
Milestone Education LLC [Member]
Adjustments to reconcile net loss to net cash (used in) operating activities:
Equity (earnings) loss on joint venture	5,493	10,455
Milestone China [Member]
Adjustments to reconcile net loss to net cash (used in) operating activities:
Equity (earnings) loss on joint venture	$ 187,062	$ (29,428)